Serial Number | 90554690 |
Word Mark | HEMERION |
Filing Date | Tuesday, March 2, 2021 |
Status | 748 - STATEMENT OF USE - TO EXAMINER |
Status Date | Wednesday, September 11, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 30, 2021 |
Goods and Services | Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical, medical and veterinary preparations for the prevention and treatment of cancer; Sanitary preparations for medical purposes; Pharmaceutical preparations for the diagnosis and treatment of oncological and inflammatory diseases and disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology |
Goods and Services | Surgical and medical apparatus and instruments, namely, surgical instruments and apparatus, medical devices for detecting and treating cancer, x-ray apparatus and surgical apparatus and instruments for medical use; Medical imaging apparatus; Medical instruments for diagnosis and treatment of cancer; Lasers for surgical and medical use; Medical apparatus for the treatment of cancerous tumors; Radiological apparatus for medical purposes; Medical imaging apparatus for use in the field of oncology for diagnostic purposes; Radiotherapy apparatus; Medical diagnostic apparatus for detecting or testing cancer; Implantable subcutaneous drug delivery apparatus, specifically, implantable drug delivery ports and implantable drug delivery pumps; fluid injectors for medical purposes; probes for medical purposes |
Goods and Services | Scientific research for medical and surgical purposes in the field of cancerous diseases; Pharmaceutical research and development; Scientific and medical research in the field of lasers; Scientific research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; Conducting clinical trials as pharmaceutical research for others in the pharmaceutical field; Conduction preclinical trials as pharmaceutical research for others in the pharmaceutical field; in-vitro testing services, specifically, in vitro pharmaceutical testing being pharmaceutical research in the pharmaceutical field; scientific studies and research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; medical, pharmacological, biological and chemical studies and research all being scientific research for surgical and medical purposes in the field of cancerous diseases; pharmaceutical research and development of new medical devices and pharmaceutical products; pharmaceutical research services, namely, performance of biological, chemical and pharmacological analyses of pharmaceutical products |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 1, 2021 |
Primary Code | 005 |
First Use Anywhere Date | Sunday, October 1, 2023 |
First Use In Commerce Date | Thursday, April 11, 2024 |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 1, 2021 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 1, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | HEMERION THERAPEUTICS |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Villeneuve-d'Ascq 59650 FR |
Party Name | HEMERION THERAPEUTICS |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Villeneuve-d'Ascq 59650 FR |
Event Date | Event Description |
Friday, March 5, 2021 | NEW APPLICATION ENTERED |
Thursday, October 21, 2021 | EXAMINERS AMENDMENT E-MAILED |
Thursday, October 21, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, October 21, 2021 | EXAMINER'S AMENDMENT ENTERED |
Thursday, October 21, 2021 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, October 21, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, October 22, 2021 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Tuesday, June 1, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, September 22, 2021 | ASSIGNED TO EXAMINER |
Tuesday, September 28, 2021 | NON-FINAL ACTION WRITTEN |
Tuesday, September 28, 2021 | NON-FINAL ACTION E-MAILED |
Tuesday, September 28, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, October 28, 2021 | ELECTRONIC RECORD REVIEW COMPLETE |
Wednesday, November 10, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 30, 2021 | PUBLISHED FOR OPPOSITION |
Tuesday, November 30, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 25, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, June 27, 2022 | SOU TEAS EXTENSION RECEIVED |
Monday, June 27, 2022 | SOU EXTENSION 1 FILED |
Monday, June 27, 2022 | SOU EXTENSION 1 GRANTED |
Wednesday, June 29, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, January 11, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, January 11, 2023 | SOU EXTENSION 2 FILED |
Wednesday, January 11, 2023 | SOU EXTENSION 2 GRANTED |
Thursday, July 20, 2023 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 20, 2023 | SOU EXTENSION 3 FILED |
Thursday, July 20, 2023 | SOU EXTENSION 3 GRANTED |
Saturday, July 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, January 19, 2024 | SOU TEAS EXTENSION RECEIVED |
Friday, January 13, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, January 19, 2024 | SOU EXTENSION 4 FILED |
Friday, January 19, 2024 | SOU EXTENSION 4 GRANTED |
Tuesday, January 23, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, July 10, 2024 | TEAS STATEMENT OF USE RECEIVED |
Wednesday, July 10, 2024 | USE AMENDMENT FILED |
Wednesday, September 11, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, September 11, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |